| Literature DB >> 9292815 |
H Spiera1, P A Asbell, D M Simpson.
Abstract
Three patients with Sjögren's syndrome (SS) who had severe xerophthalmia and blepharospasm received botulinum toxin injections for the treatment of their blepharospasm. They had a remarkable increase in tearing, measured by Schirmer's test, and a decrease in signs and symptoms of dry eyes after botulinum toxin injection periorbitally for blepharospasm. The mechanism for this increased tearing is unclear, but suggests a potential treatment for patients with severe xerophthalmia with SS.Entities:
Mesh：
Substances：
Year: 1997 PMID： 9292815
Source DB: PubMed Journal: J Rheumatol ISSN： 0315-162X Impact factor: 4.666